Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Raised to $57 at Barclays on 2Q Beat & FY17 EPS Raise; '2H Outlook Appears Bright'

July 21, 2017 8:32 AM
Barclays raised its price target on Abbott Labs (NYSE: ABT) to $57.00 (from $52.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles